Jan 09, 2016
3CTN-funded clinical trial to test new method of finding genomic changes in patients with aggressive prostate cancer
Oct 14, 2015
OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers
Feb 25, 2015
OICR extends collaboration with Janssen Inc. to develop clinical trials for prostate cancer
Receive the latest news, event invites, funding opportunities and more from the Ontario Institute for Cancer Research.